GRFS
Grifols S.A.
Company Overview
| Mkt Cap | $6.44B | Price | $9.37 |
| Volume | 756.66K | Change | +2.29% |
| P/E Ratio | 41.0 | Open | $9.25 |
| Revenue | $7.2B | Prev Close | $9.16 |
| Net Income | $156.9M | 52W Range | $6.19 - $11.14 |
| Div Yield | 0.17% | Target | $12.15 |
| Overall | 46 | Value | 50 |
| Quality | 39 | Technical | 50 |
No chart data available
Stock Overview
Updated DailyGrifols S.A. (GRFS) is a leading Healthcare company in the Biotechnology industry, currently trading at $9.37 with a market capitalization of $6.44 billion. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows GRFS with a volume of 757K shares. The stock opened up 0.98% from yesterday's close of $9.16. Current analyst estimates project earnings of $1.03 per share for this year, with next year targeting $1.34.
GRFS demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including BAX, AMGN, CO, JNJ, KMB.
Key investment considerations for GRFS include below-average investment characteristics. The company offers a dividend yield of 0.173385% and analyst price targets suggest potential upside of 29.7%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 3, 2025 at 07:30 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GRFS | $9.37 | +2.3% | 756.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |